These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16304570)

  • 21. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
    Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country.
    Chan LL; Abdel-Latif ME; Ariffin WA; Ariffin H; Lin HP
    Br J Haematol; 2004 Sep; 126(6):799-805. PubMed ID: 15352983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia.
    Dluzniewska A; Balwierz W; Armata J; Balcerska A; Chybicka A; Kowalczyk J; Matysiak M; Ochocka M; Radwanska U; Rokicka-Milewska R; Sonta-Jakimczyk D; Wachowiak J; Wysocki M
    Leukemia; 2005 Dec; 19(12):2117-24. PubMed ID: 16107894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
    Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
    Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials.
    Sander A; Zimmermann M; Dworzak M; Fleischhack G; von Neuhoff C; Reinhardt D; Kaspers GJ; Creutzig U
    Leukemia; 2010 Aug; 24(8):1422-8. PubMed ID: 20535146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved treatment results for childhood acute myeloid leukemia in Taiwan.
    Liang DC; Chan TT; Lin KH; Lin DT; Lu MY; Chen SH; Liu HC; Lin MT; Lee MT; Shu SG; Chang TK; Chen JS; Hsiao CC; Hung IJ; Hsieh YL; Chen RL; Cheng SN; Chang WH; Lee CH; Lin KS
    Leukemia; 2006 Jan; 20(1):136-41. PubMed ID: 16281075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current results of cooperative AML therapy studies in children: BFM-78 and 83].
    Creutzig U; Ritter J; Budde M; Riehm H; Henze G; Lampert F; Gerein V; Müller-Weihrich S; Niethammer D; Spaar HJ
    Klin Padiatr; 1986; 198(3):183-90. PubMed ID: 3523024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a curative treatment within the AML-BFM studies.
    Creutzig U; Zimmermann M; Dworzak MN; Ritter J; Schellong G; Reinhardt D
    Klin Padiatr; 2013 May; 225 Suppl 1():S79-86. PubMed ID: 23700063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.
    Smith FO; Alonzo TA; Gerbing RB; Woods WG; Arceci RJ;
    Leukemia; 2005 Dec; 19(12):2054-62. PubMed ID: 16136168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
    Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
    Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia].
    Dłuzniewska A; Balwierz W; Balcerska A; Chybicka A; Kamieńska E; Karolczyk G; Karpińska-Derda I; Krawczuk-Rybak M; Kowalczyk JR; Lewandowska D; Maciejka-Kapuścińska L; Kołtano S; Malinowska I; Matysiak M; Mikołajczyk M; Mizia-Malarz A; Muszyńska-Rosłan K; Niedźwiedzki M; Pohorecka J; Sikorska-Fic B; Sobol G; Sońta-Jakimczyk D; Tomaszewska R; Urasiński T; Wachowiak J; Wieczorek M; Wójcik B; Wysocki M
    Przegl Lek; 2010; 67(6):366-70. PubMed ID: 21344763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.
    Vormoor J; Ritter J; Creutzig U; Boos J; Heyen P; Ludwig WD; Harbott J; Löffler H; Schellong G
    Br J Cancer Suppl; 1992 Aug; 18():S63-7. PubMed ID: 1503929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
    Creutzig U; Reinhardt D; Diekamp S; Dworzak M; Stary J; Zimmermann M
    Leukemia; 2005 Aug; 19(8):1355-60. PubMed ID: 15920490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.
    Conter V; Aricò M; Basso G; Biondi A; Barisone E; Messina C; Parasole R; De Rossi G; Locatelli F; Pession A; Santoro N; Micalizzi C; Citterio M; Rizzari C; Silvestri D; Rondelli R; Lo Nigro L; Ziino O; Testi AM; Masera G; Valsecchi MG;
    Leukemia; 2010 Feb; 24(2):255-64. PubMed ID: 20016536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of poor response paediatric AML using early SCT.
    Wareham NE; Heilmann C; Abrahamsson J; Forestier E; Gustafsson B; Ha SY; Heldrup J; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Hasle H
    Eur J Haematol; 2013 Mar; 90(3):187-94. PubMed ID: 23215948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.
    Ribeiro RC; Razzouk BI; Pounds S; Hijiya N; Pui CH; Rubnitz JE
    Leukemia; 2005 Dec; 19(12):2125-9. PubMed ID: 16281077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses.
    Creutzig U; Zimmermann M; Dworzak M; Urban C; Henze G; Kremens B; Lakomek M; Bourquin JP; Stary J; Reinhardt D
    Br J Haematol; 2010 May; 149(3):399-409. PubMed ID: 20230404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.